Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wenger

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Journal of Veterinary Internal Medicine|December 15, 2010
Remission of diabetes mellitus in cats cannot be predicted by the arginine stimulation testF Tschuor, E Zini, S Schellenberg, et al.
Genome Research|February 6, 2013
PRISM offers a comprehensive genomic approach to transcription factor function predictionAaron M Wenger, Shoa L Clarke, Harendra Guturu, et al.
Applied Ergonomics|February 28, 2021
A novel assistive therapy chair to improve trunk control during neurorehabilitation: Perceptions of physical therapists and patientsC M Bauer, I Nast, M Scheermesser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 13, 2018
Phrank measures phenotype sets similarity to greatly improve Mendelian diagnostic disease prioritizationKarthik A Jagadeesh, Johannes Birgmeier, Harendra Guturu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Transplantation|August 1, 1988
Molecular characteristics of cyclophilin-cyclosporine interactionV F Quesniaux, M H Schreier, R M Wenger, et al.
European Journal of Gynaecological Oncology|August 24, 2013
P16 immunostaining and HPV testing in histological specimens from the uterine cervixG Capobianco, V Marras, J M Wenger, et al.
European Journal of Nuclear Medicine|January 19, 2000
Thallium-201 gated single-photon emission tomography for the assessment of left ventricular ejection fraction and regional wall motion abnormalities in comparison with two-dimensional echocardiographyC Bacher-Stier, S Müller, O Pachinger, et al.
European Journal of Immunology|September 1, 1987
Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activityV F Quesniaux, M H Schreier, R M Wenger, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Journal of Veterinary Internal Medicine|December 15, 2010
Remission of diabetes mellitus in cats cannot be predicted by the arginine stimulation testF Tschuor, E Zini, S Schellenberg, et al.
Genome Research|February 6, 2013
PRISM offers a comprehensive genomic approach to transcription factor function predictionAaron M Wenger, Shoa L Clarke, Harendra Guturu, et al.
Applied Ergonomics|February 28, 2021
A novel assistive therapy chair to improve trunk control during neurorehabilitation: Perceptions of physical therapists and patientsC M Bauer, I Nast, M Scheermesser, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 13, 2018
Phrank measures phenotype sets similarity to greatly improve Mendelian diagnostic disease prioritizationKarthik A Jagadeesh, Johannes Birgmeier, Harendra Guturu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Transplantation|August 1, 1988
Molecular characteristics of cyclophilin-cyclosporine interactionV F Quesniaux, M H Schreier, R M Wenger, et al.
European Journal of Gynaecological Oncology|August 24, 2013
P16 immunostaining and HPV testing in histological specimens from the uterine cervixG Capobianco, V Marras, J M Wenger, et al.
European Journal of Nuclear Medicine|January 19, 2000
Thallium-201 gated single-photon emission tomography for the assessment of left ventricular ejection fraction and regional wall motion abnormalities in comparison with two-dimensional echocardiographyC Bacher-Stier, S Müller, O Pachinger, et al.
European Journal of Immunology|September 1, 1987
Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activityV F Quesniaux, M H Schreier, R M Wenger, et al.
Pageof 17